Description
Novel Autism Diagnostics
Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.
Table of Contents
ONE: EXECUTIVE SUMMARY
Overview of ASD
Leading Competitors
Methodology
TWO: NOVEL AUTISM DIAGNOSTICS
Overview of Autism
Screening and Diagnosis
Developmental Screening
Comprehensive Diagnostic Evaluation
Emerging Diagnostics
Potential Market
Research
THREE: COMPANY PROFILES
Ambry Genetics Corp.
ARUP Laboratories
Asuragen Inc.
Controls
Sample Collection
Sequencing
Athena Diagnostics, Inc. (A Quest Diagnostics Business)
Claritas Genomics, Inc.
CombiMatrix Corp.
Oncology
Courtagen Life Sciences, Inc.
Emory Genetics Laboratory
GenePeeks, Inc.
Genoma SA (a Subsidiary of the Esperite group)
Google Genomics
Greenwood Genetic Center
Illumina
Sequencing
Sequencing Kits
Sample Prep
IVD Business
Oncology
HLA Typing
IT
Forensics
CLIA Lab Service
Nanopore Sequencing
Sample to Insight
Making a Market
IP Situation
IntegraGen
LabCorp, Laboratory Corporation of America
Infectious Diseases
Prenatal
Sequencing
Oncology
BRCA Saga
Information Technology
Forensic
Collaborations
Life Technologies Corporation
Instrumentation and Applications
Liquid Biopsy
Sequencing
Life Technologies an IVD Company
Partnerships Worldwide
Life and Quidel Develop Diagnostics on the 7500 Fast Dx
Sepsis
HIV
Emerging Pathogens
Bacterial Typing
Personalized Medicine
Forensic
Lineagen, Inc.
MEDomics, LLC
Population Diagnostics
RainDance Technologies, Inc.
SynapDx Corporation
Transgenomic, Inc.
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Table 1-1: Identified Prevalence of Autism Spectrum Disorder (ADDM Network, 2000-2010)
TWO: NOVEL AUTISM DIAGNOSTICS
Table 2-1: Selected Autism Test Innovations
Table 2-2: Global Clinical Laboratory Services Market for Neonatal and Pediatric Testing, 2015 and 2020
Table 2-3: Geographical Distribution of Laboratories Performing Genetic Testing Services
